162 related articles for article (PubMed ID: 25588741)
1. Potent antitumor activity of Oct4 and hypoxia dual-regulated oncolytic adenovirus against bladder cancer.
Lu CS; Hsieh JL; Lin CY; Tsai HW; Su BH; Shieh GS; Su YC; Lee CH; Chang MY; Wu CL; Shiau AL
Gene Ther; 2015 Apr; 22(4):305-15. PubMed ID: 25588741
[TBL] [Abstract][Full Text] [Related]
2. Tumor-selective replication of an oncolytic adenovirus carrying oct-3/4 response elements in murine metastatic bladder cancer models.
Wu CL; Shieh GS; Chang CC; Yo YT; Su CH; Chang MY; Huang YH; Wu P; Shiau AL
Clin Cancer Res; 2008 Feb; 14(4):1228-38. PubMed ID: 18281558
[TBL] [Abstract][Full Text] [Related]
3. The inhibitory effect of hypoxic cytotoxin on the expansion of cancer stem cells in ovarian cancer.
Nozawa-Suzuki N; Nagasawa H; Ohnishi K; Morishige K
Biochem Biophys Res Commun; 2015 Feb; 457(4):706-11. PubMed ID: 25619133
[TBL] [Abstract][Full Text] [Related]
4. Targeted cancer gene therapy using a hypoxia inducible factor dependent oncolytic adenovirus armed with interleukin-4.
Post DE; Sandberg EM; Kyle MM; Devi NS; Brat DJ; Xu Z; Tighiouart M; Van Meir EG
Cancer Res; 2007 Jul; 67(14):6872-81. PubMed ID: 17638898
[TBL] [Abstract][Full Text] [Related]
5. Oncolytic effects of adenovirus mutant capable of replicating in hypoxic and normoxic regions of solid tumor.
Cho WK; Seong YR; Lee YH; Kim MJ; Hwang KS; Yoo J; Choi S; Jung CR; Im DS
Mol Ther; 2004 Nov; 10(5):938-49. PubMed ID: 15509511
[TBL] [Abstract][Full Text] [Related]
6. Oct4 and Hypoxia Dual-Regulated Oncolytic Adenovirus Armed with shRNA-Targeting Dendritic Cell Immunoreceptor Exerts Potent Antitumor Activity against Bladder Cancer.
Hu CY; Hung CF; Chen PC; Hsu JY; Wang CT; Lai MD; Tsai YS; Shiau AL; Shieh GS; Wu CL
Biomedicines; 2023 Sep; 11(10):. PubMed ID: 37892972
[TBL] [Abstract][Full Text] [Related]
7. Second-generation HIF-activated oncolytic adenoviruses with improved replication, oncolytic, and antitumor efficacy.
Cherry T; Longo SL; Tovar-Spinoza Z; Post DE
Gene Ther; 2010 Dec; 17(12):1430-41. PubMed ID: 20664541
[TBL] [Abstract][Full Text] [Related]
8. Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus.
Zhang Q; Chen G; Peng L; Wang X; Yang Y; Liu C; Shi W; Su C; Wu H; Liu X; Wu M; Qian Q
Clin Cancer Res; 2006 Nov; 12(21):6523-31. PubMed ID: 17085667
[TBL] [Abstract][Full Text] [Related]
9. Cancer therapy with a replicating oncolytic adenovirus targeting the hypoxic microenvironment of tumors.
Post DE; Devi NS; Li Z; Brat DJ; Kaur B; Nicholson A; Olson JJ; Zhang Z; Van Meir EG
Clin Cancer Res; 2004 Dec; 10(24):8603-12. PubMed ID: 15623644
[TBL] [Abstract][Full Text] [Related]
10. A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma.
Wang Y; Liu T; Huang P; Zhao H; Zhang R; Ma B; Chen K; Huang F; Zhou X; Cui C; Liu X
Oncotarget; 2015 May; 6(15):13564-78. PubMed ID: 25980438
[TBL] [Abstract][Full Text] [Related]
11. [Silencing hypoxia inducible factor-2α gene by small interference RNA inhibits the growth of mammosphere cells in nude mice under hypoxic microenvironment].
Qu HB; Fan YM; Han ML; Zeng N; Zhu ZK; Liu H; Xie J; Wu CY; Tang WX
Zhonghua Yi Xue Za Zhi; 2013 Apr; 93(15):1182-7. PubMed ID: 23902893
[TBL] [Abstract][Full Text] [Related]
12. Genetic delivery of an immunoRNase by an oncolytic adenovirus enhances anticancer activity.
Fernández-Ulibarri I; Hammer K; Arndt MA; Kaufmann JK; Dorer D; Engelhardt S; Kontermann RE; Hess J; Allgayer H; Krauss J; Nettelbeck DM
Int J Cancer; 2015 May; 136(9):2228-40. PubMed ID: 25303768
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy targeting hepatocellular carcinoma by a dual-regulated oncolytic adenovirus harboring the focal adhesion kinase shRNA.
Gao Y; Zhu Y; Huang X; Ai K; Zheng Q; Yuan Z
Int J Oncol; 2015 Aug; 47(2):668-78. PubMed ID: 26081241
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapeutic sensitivity of testicular germ cell tumors under hypoxic conditions is negatively regulated by SENP1-controlled sumoylation of OCT4.
Wu YC; Ling TY; Lu SH; Kuo HC; Ho HN; Yeh SD; Shen CN; Huang YH
Cancer Res; 2012 Oct; 72(19):4963-73. PubMed ID: 23002208
[TBL] [Abstract][Full Text] [Related]
15. Low-dose etoposide enhances telomerase-dependent adenovirus-mediated cytosine deaminase gene therapy through augmentation of adenoviral infection and transgene expression in a syngeneic bladder tumor model.
Shieh GS; Shiau AL; Yo YT; Lin PR; Chang CC; Tzai TS; Wu CL
Cancer Res; 2006 Oct; 66(20):9957-66. PubMed ID: 17047058
[TBL] [Abstract][Full Text] [Related]
16. Oncolytic adenovirus-mediated dual knockdown of survivin and OCT4 improves therapeutic efficacy in esophageal cancer.
Li C; Zhu M; Lu Q; Yu B; Yang Y; Li B; Peng Z; Li Z
Ann Transl Med; 2023 Mar; 11(5):193. PubMed ID: 37007541
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced, perinecrotic expression of endothelial Per-ARNT-Sim domain protein-1/hypoxia-inducible factor-2alpha correlates with tumor progression, vascularization, and focal macrophage infiltration in bladder cancer.
Onita T; Ji PG; Xuan JW; Sakai H; Kanetake H; Maxwell PH; Fong GH; Gabril MY; Moussa M; Chin JL
Clin Cancer Res; 2002 Feb; 8(2):471-80. PubMed ID: 11839666
[TBL] [Abstract][Full Text] [Related]
18. CG0070, a conditionally replicating granulocyte macrophage colony-stimulating factor--armed oncolytic adenovirus for the treatment of bladder cancer.
Ramesh N; Ge Y; Ennist DL; Zhu M; Mina M; Ganesh S; Reddy PS; Yu DC
Clin Cancer Res; 2006 Jan; 12(1):305-13. PubMed ID: 16397056
[TBL] [Abstract][Full Text] [Related]
19. Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines.
Jones A; Fujiyama C; Blanche C; Moore JW; Fuggle S; Cranston D; Bicknell R; Harris AL
Clin Cancer Res; 2001 May; 7(5):1263-72. PubMed ID: 11350893
[TBL] [Abstract][Full Text] [Related]
20. NcoA2-Dependent Inhibition of HIF-1α Activation Is Regulated via AhR.
Tsai CH; Li CH; Liao PL; Cheng YW; Lin CH; Huang SH; Kang JJ
Toxicol Sci; 2015 Dec; 148(2):517-30. PubMed ID: 26350169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]